Cargando…
Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients
Neurofibromatosis type 1 (NF1) is a hereditary tumor syndrome caused by mutations of the NF1 gene and resulting dysregulation of the Ras-pathway. In addition to peripheral nerve tumors, affected tissues include the musculoskeletal and cardiovascular system. The immune system has recently been sugges...
Autores principales: | Farschtschi, Said, Park, Su-Jin, Sawitzki, Birgit, Oh, Su-Jun, Kluwe, Lan, Mautner, Victor F., Kurtz, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995232/ https://www.ncbi.nlm.nih.gov/pubmed/27448806 http://dx.doi.org/10.1007/s00262-016-1871-0 |
Ejemplares similares
-
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors
por: Park, Su-Jin, et al.
Publicado: (2013) -
Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth
por: Well, Lennart, et al.
Publicado: (2021) -
Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target
por: Farschtschi, Said, et al.
Publicado: (2020) -
Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
por: Well, Lennart, et al.
Publicado: (2021) -
Presenting symptoms in children with neurofibromatosis type 2
por: Gugel, Isabel, et al.
Publicado: (2020)